Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN
· Real-Time Price · USD
9.20
-0.19 (-2.02%)
At close: Oct 03, 2025, 3:16 PM
9.07
-1.41%
After-hours: Oct 03, 2025, 04:00 PM EDT
Addex Therapeutics Ltd Income Statement
Financials in CHF. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 162.78K | 241.68K | 405.53K | 557.48K | 831.37K | 1.35M | 1.61M | 2.05M | 2.13M | 1.69M | 1.42M | 1.23M | 1.5M | 2.31M | 2.92M | 4.34M | 3.68M | 3.55M |
Cost of Revenue | 156.07K | 494.38K | 338.23K | 1.88M | 3.69M | 5.23M | 6.94M | 20.01M | 20.97M | 24.84M | 26.9M | 25.1M | 22.33M | 20.32M | 19.3M | 9M | 10.98M | 9.57M |
Gross Profit | 6.71K | 85.61K | 405.62K | -988.78K | -2.52M | -3.88M | -5.32M | -17.96M | -18.83M | -23.15M | -25.48M | -23.87M | -20.83M | -18.01M | -16.38M | -4.66M | -7.3M | -6.02M |
Operating Income | -2.41M | -2.57M | -2.76M | -3.04M | -5.07M | -6.72M | -8.33M | -11.1M | -12.61M | -17.16M | -20.52M | -21.3M | -20.71M | -18.12M | -15.51M | -13.11M | -12.65M | -11.12M |
Interest Income | 87.00 | 1.59K | 9.16K | 22.31K | 35.87K | 47.71K | 63.96K | 76.18K | 66.13K | 52.98K | 29.25K | 4.66K | 2.29K | 3.81K | 532.87K | 533.37K | 533.41K | 542.53K |
Pretax Income | -6.15M | -5.65M | -4.91M | -4.62M | -5.71M | -6.93M | -8.6M | -11.35M | -12.84M | -17.39M | -20.8M | -21.58M | -21.07M | -18.54M | -15.35M | -13.05M | -12.77M | -11.19M |
Net Income | -6.05M | 8.67M | 7.06M | 5.4M | 4.32M | -11.24M | -10.56M | -11.35M | -12.84M | -17.39M | -20.8M | -21.58M | -21.07M | -18.54M | -15.35M | -13.05M | -12.77M | -11.19M |
Selling & General & Admin | 1.58M | 1.55M | 1.88M | 2.35M | 3.77M | 5.21M | 6.24M | 5.26M | 5.9M | 5.48M | 5.92M | 6.66M | 5.74M | 6.06M | 5.14M | 5.28M | 5.09M | 4.83M |
Research & Development | 338.65K | 288.66K | 501.2K | 656.5K | 1.41M | 1.98M | 2.44M | 8.04M | 8.94M | 13.94M | 16.99M | 14.75M | 15.87M | 13.86M | 12.84M | 14.4M | 12.71M | 11.3M |
Other Expenses | 579.34K | 902.31K | 776.7K | 434.84K | 173.9K | -149.06K | 241.06K | -1.02M | -573.14K | -576.23K | -966.36K | 445.35K | -3.09K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 2.5M | 2.74M | 3.16M | 3.45M | 5.75M | 7.91M | 9.79M | 13.15M | 14.75M | 18.84M | 21.94M | 22.52M | 22.21M | 20.43M | 18.42M | 17.45M | 16.34M | 14.67M |
Interest Expense | 2.62K | 3.48K | 3.55K | 10.42K | 13.33K | 16.3K | 16.3K | 15.71K | 18.59K | 27.09K | 48.9K | 50.47K | 54.08K | 64.69K | 63.01K | 63.94K | 66.49K | 61.68K |
Selling & Marketing Expenses | n/a | n/a | 203.2K | 203.2K | 203.2K | 203.2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.5M | 2.74M | 3.16M | 5.55M | 7.85M | 10.02M | 11.89M | 13.15M | 14.75M | 18.84M | 21.94M | 22.52M | 22.21M | 20.43M | 18.42M | 17.45M | 16.34M | 14.67M |
Income Tax Expense | n/a | n/a | n/a | n/a | 3.5K | 7.33K | 65.35K | 65.35K | 61.85K | 58.23K | 300.00 | 9.64K | 19.63K | 42.37K | 42.27K | 43.2K | 45.75K | 40.94K |
Shares Outstanding (Basic) | 721.04K | 819.54K | 815.2K | 812.79K | 812.79K | 812.79K | 793.64K | 643.99K | 601.57K | 510.41K | 497.46K | 398.21K | 312.23K | 315.79K | 289.81K | 284.35K | 283.83K | 279.33K |
Shares Outstanding (Diluted) | 767.15K | 819.54K | 815.2K | 812.79K | 812.79K | 812.79K | 793.64K | 643.99K | 601.57K | 510.41K | 497.46K | 398.21K | 312.23K | 315.79K | 289.81K | 284.35K | 283.83K | 279.33K |
EPS (Basic) | -7.69 | 10.46 | 8.46 | 6.31 | 4.13 | -15.6 | -16.8 | -20.4 | -26.4 | -45.6 | -58.8 | -67.2 | -69.6 | -63.6 | -55.2 | -49.2 | -50.4 | -48 |
EPS (Diluted) | -7.72 | 10.44 | 8.44 | 6.31 | 4.13 | -15.6 | -16.8 | -20.4 | -26.4 | -45.6 | -58.8 | -67.2 | -69.6 | -63.6 | -55.2 | -49.2 | -50.4 | -48 |
EBITDA | -4.84M | -5.45M | -4.65M | -6.25M | -7.34M | -8.59M | -8.29M | -9.09M | -10.61M | -15.14M | -20.49M | -21.26M | -20.67M | -18.13M | -14.94M | -12.64M | -12.34M | -10.76M |
EBIT | -4.92M | -5.64M | -4.91M | -6.57M | -7.65M | -8.87M | -8.5M | -9.3M | -10.79M | -15.32M | -20.76M | -21.53M | -21.01M | -18.47M | -15.29M | -12.99M | -12.7M | -11.13M |
Depreciation & Amortization | 81.61K | 191.88K | 260.12K | 315.7K | 337.51K | 300.53K | 305.95K | 302.21K | 304.15K | 312.09K | 323.14K | 330.46K | 340.88K | 345.8K | 347.61K | 351.72K | 362.99K | 371.24K |